Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study

ISRCTN ISRCTN56551999
DOI https://doi.org/10.1186/ISRCTN56551999
Submission date
19/10/2006
Registration date
06/12/2006
Last edited
25/10/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Peter de Leeuw
Scientific

P Debyelaan 25
5800
Maastricht
6229 AZ
Netherlands

Email Ple@sint.azm.nl

Study information

Study designA multicentre prospective randomised clinical trial with a parallel group design. Patients are followed-up for a period of one year.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific titleHome versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study
Study acronymHOMERUS
Study objectivesAntihypertensive treatment based on self measured blood pressure values may lead to less use of drugs without leading to worse blood pressure control or more target organ damage as compared to patients who are treated based on conventional office blood pressure measurement.
Ethics approval(s)Informed consent, in accordance with the declaration of Helsinki, has been obtained from all patients prior to entering the study. Good clinical practice is maintained and the study protocol has been approved by the ethical committees of all participating centres before inclusion of patients into the study.
Health condition(s) or problem(s) studiedHypertension
InterventionGroup one: patients receive antihypertensive treatment on the basis of self blood pressure measurement.
Group two: patients are treated based on conventional office blood pressure measurement.
Intervention typeOther
Primary outcome measure1. Blood pressure value (conventional office blood pressure and 24 hour ambulatory blood pressure)
2. Target organ damage (kidney, heart)
3. Cost and number of antihypertensive drugs
Secondary outcome measures1. Compliance with treatment
2. Quality of life
Overall study start date01/10/2001
Completion date01/10/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants430 (216 self-measured pressures, 214 office pressures)
Key inclusion criteria1. Males and females aged 18 years and above
2. Average blood pressure between 139 and 200 mmHg for systolic or between 90 and 120 mmHg for diastolic blood pressure
3. Participating subjects are physically and mentally able to measure their own blood pressure
4. Subjects are willing to remain in follow-up during a period of one year
5. Signed informed consent
Key exclusion criteria1. The presence of clinically manifest cardiovascular events (angina pectoris, heart failure, hypertensive encephalopathy, or prior myocardial infarction or cerebrovascular accident)
2. Severe non-cardiovascular disease (e.g. malignancy), which will interfere with adequate follow up
3. Allergy or contra-indications for the antihypertensive drugs used in this study
4. Serum creatinine above 150 micromol/l
5. Clinically significant orthostatic hypotension (a drop in systolic blood pressure of more than 20 mmHg upon standing)
6. Blood pressure devices
Date of first enrolment01/10/2001
Date of final enrolment01/10/2004

Locations

Countries of recruitment

  • Netherlands

Study participating centre

P Debyelaan 25
Maastricht
6229 AZ
Netherlands

Sponsor information

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Research organisation

PO Box 93245
Den Haag
2509 AE
Netherlands

Email info@zonmw.nl
Website http://www.zonmw.nl/nl/home/contact.html
ROR logo "ROR" https://ror.org/01yaj9a77

Funders

Funder type

Research organisation

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands) (ref: 945-01-043)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other publications 01/08/2003 Yes No
Other publications 01/08/2005 Yes No
Other publications 01/08/2006 Yes No
Results article 01/12/2007 Yes No
Results article 01/12/2007 Yes No

Editorial Notes

25/10/2022: Internal review.